Scarica l'app Stockscreener
2.40
1.64%
-0.04
Pre-mercato:
2.46
0.06
+2.50%
Precedente Chiudi:
$2.44
Aprire:
$2.44
Volume 24 ore:
628.84K
Relative Volume:
0.73
Capitalizzazione di mercato:
$202.14M
Reddito:
$70.14M
Utile/perdita netta:
$-76.24M
Rapporto P/E:
-2.1622
EPS:
-1.11
Flusso di cassa netto:
$-57.06M
1 W Prestazione:
-4.00%
1M Prestazione:
+4.35%
6M Prestazione:
-49.69%
1 anno Prestazione:
-19.73%
Intervallo 1D:
$2.39
$2.505
Intervallo di 1 settimana:
$2.32
$2.58
Portata 52W:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Nome
Codexis Inc
Settore
Industria
Telefono
650-421-8100
Indirizzo
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Confronta CDXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.40 | 202.14M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-19 | Downgrade | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Ripresa | Piper Sandler | Overweight |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2021-04-12 | Iniziato | Piper Sandler | Overweight |
| 2021-03-01 | Iniziato | Stifel | Buy |
| 2021-02-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-10 | Iniziato | The Benchmark Company | Buy |
| 2019-01-17 | Aggiornamento | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Iniziato | Stephens | Overweight |
| 2017-10-13 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-31 | Iniziato | Jefferies | Buy |
| 2017-01-26 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Codexis Inc Borsa (CDXS) Ultime notizie
Synthetic Biology Market Key Players AnalysisBota - openPR.com
Codexis, Inc. (NASDAQ:CDXS) Position Increased by Assenagon Asset Management S.A. - Defense World
Opaleye Management Makes a Bold Move with Codexis Stock Purchase! - TipRanks
Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Bank of America Corp DE Has $364,000 Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Cantor Fitzgerald Forecasts Codexis FY2026 Earnings - Defense World
Squarepoint Ops LLC Has $253,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Investor Network: Codexis, Inc. to Host Earnings Call - ACCESS Newswire
Two Sigma Investments LP Buys 6,397 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis at Jefferies Global Healthcare Conference: Enzymatic Synthesis Insights By Investing.com - Investing.com Canada
ProShare Advisors LLC Has $127,000 Stake in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Deutsche Bank AG Raises Holdings in Codexis, Inc. (NASDAQ:CDXS) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $218,000 Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io
Opaleye Management Makes a Bold Move with Massive Codexis Stock Purchase - TipRanks
Group One Trading LLC Buys Shares of 15,226 Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis, Inc. (NASDAQ:CDXS) Stake Lifted by Northern Trust Corp - Defense World
Codexis’ Landmark Presentations at TIDES USA Highlight - GlobeNewswire
Transcript : Codexis, Inc.Special Call - marketscreener.com
Codexis (CDXS) Showcases Innovations in siRNA Manufacturing at T - GuruFocus
Codexis (CDXS) Showcases Innovations in siRNA Manufacturing at TIDES USA | CDXS Stock News - GuruFocus
Codexis Highlights Advancements in Eco Synthesis Technology for siRNA Manufacturing at TIDES USA Conference - Nasdaq
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - GlobeNewswire
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process ... - Bluefield Daily Telegraph
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - GlobeNewswire Inc.
Codexis to Participate in Jefferies Global Healthcare Conference - The Manila Times
Codexis to Participate in Jefferies Global Healthcare Conference | CDXS Stock News - GuruFocus
Argan Strengthens Board with Energy Giant Sempra Executive: Strategic Growth Move - Stock Titan
Codexis’s SWOT analysis: innovative enzyme firm’s stock poised for growth - Investing.com Australia
Codexis’s SWOT analysis: innovative enzyme firm’s stock poised for growth By Investing.com - Investing.com Canada
Former Genentech and Codexis Legal Leader Takes Top Legal Role at Liver Disease Biotech Aligos - Stock Titan
Codexis, Inc. (NASDAQ:CDXS) Shares Bought by Ameriprise Financial Inc. - Defense World
Cantor Fitzgerald Lowers Earnings Estimates for Codexis - Defense World
Codexis (NASDAQ:CDXS) Stock Rating Upgraded by StockNews.com - Defense World
Price T Rowe Associates Inc. MD Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
Codexis, Inc. (NASDAQ:CDXS) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Codexis, Inc. (NASDAQ:CDXS) Q1 2025 Earnings Call Transcript - Insider Monkey
Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Stifel Financial Corp - Defense World
Codexis Earnings Call: Strategic Growth Amid Challenges - TipRanks
Codexis reiterates $64M-$68M 2025 revenue guidance as ecosynthesis platform gains traction with CDMOs - MSN
Stifel maintains Buy rating on Codexis stock with $5 target By Investing.com - Investing.com India
Stifel maintains Buy rating on Codexis stock with $5 target - Investing.com
Codexis May 2025 presentation slides: RNA manufacturing pivot targets path to profitability - Investing.com Canada
Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with Strategic Growth Initiatives - GuruFocus
Codexis Inc (CDXS) Q1 2025 Earnings: EPS at -$0.23 and Revenue H - GuruFocus
Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with ... - Yahoo Finance
Codexis Reports Q1 2025 Financial Results and Strategic Progress - TipRanks
Codexis: Q1 Earnings Snapshot - MySA
Earnings call transcript: Codexis Q1 2025 results miss forecasts, stock declines - Investing.com Nigeria
Codexis (CDXS) Navigates Q1 Revenue Challenges, Confirms 2025 Ou - GuruFocus
Codexis Inc Azioni (CDXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Codexis Inc Azioni (CDXS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jun 13 '25 |
Buy |
2.23 |
99,102 |
220,997 |
12,199,102 |
| Opaleye Management Inc. | 10% Owner |
Jun 16 '25 |
Buy |
2.24 |
50,898 |
114,012 |
12,250,000 |
| Opaleye Management Inc. | 10% Owner |
May 23 '25 |
Buy |
2.36 |
2,320,000 |
5,475,200 |
11,995,000 |
| Opaleye Management Inc. | 10% Owner |
May 28 '25 |
Buy |
2.36 |
5,000 |
11,800 |
12,000,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 30 '25 |
Buy |
2.31 |
25,000 |
57,660 |
9,655,000 |
| Opaleye Management Inc. | 10% Owner |
May 01 '25 |
Buy |
2.32 |
20,000 |
46,436 |
9,675,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 25 '25 |
Buy |
2.24 |
25,000 |
55,915 |
9,630,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 16 '25 |
Buy |
2.13 |
70,000 |
148,890 |
9,560,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 17 '25 |
Buy |
2.09 |
45,000 |
94,162 |
9,605,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 15 '25 |
Buy |
2.23 |
25,000 |
55,720 |
9,490,000 |
0.39%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):